Advances in Yupingfeng San Research: Multi-Target Mechanisms and Clinical Evidence.

Drug Des Devel Ther · 2026 · PMC13196821 · PMID 42182585

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

In terms of total nasal symptom score (TNSS) and visual analogue scale (VAS), the YPFS group showed a trend of improvement, indicating its potential in alleviating core AR symptoms.

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.